The Scope E-Newsletter
From the Dean's Office
UTGSM Remembers Dr. George F. Schuchmann
UTGSM and Its Programs Earn Maximum Accreditations
In the Spotlight
Clinical Trials Bring New, Advanced Treatment for Emergency Condition of Aorta
COM Students on GSM's Medical School Task Force Provide Double Perspective
OB/GYN Residents Broaden Skills While Serving Guatemalan Women in Need
New Laboratory Focuses on Regenerative Medicine and High School Outreach
Surgery Alumnus Recounts First Weekend of Solo Trauma Attending Call
The Life and Work of Dr. Solomon Featured in UT Achievement Magazine
Surgery Resident Dr. Gandhi Presents ODAM Research to Melanoma Experts in Australia
Pathology Society Awards Dr. Sneed for Resident Research
Faculty and Staff Honored for Long-Term Service
Residents and Fellows Engage in Knoxville's Medical Community
Rawn Achieves Professional Research Certification
Genetic Counselor Putnam Earns Board Certification
News
UTMC and Community Hospitals Support Tobacco Free Campuses
UTHSC Celebrates 100 Years; Centennial Book Available
Women's Health Featured in Frontiers Magazine
Save the Date: Resident and Fellows' Research Days
Research @ Lunch Spring 2011 Meetings Set
January Resident Business Course Examines Contracts
Continuing Medical and Dental Education
Register Today: Diabetes Conference, March 19
CME Courses at UTK Focus on Lean Healthcare and Change
Oral Surgeons Learn About Trauma Management
Scholarly Activity
Surgery Resident Dr. Gandhi Presents ODAM Research to Melanoma Experts in Australia
Sagar Gandhi, MD, Surgery Resident, recently returned from Sydney, Australia, where he presented, "ODAM, A Novel Tight Junction Protein, Predicts Sentinel Node Metastasis in Cutaneous Melanoma," at the 7th International Melanoma Research Congress, considered one of the most comprehensive melanoma conferences available. Dr. Gandhi was the only resident invited to speak among a group of international soft tissue cancer experts, and his presentation marks the second time a UT Graduate School of Medicine resident has spoken internationally on Odontogenic Ameloblast associated protein (ODAM) and its characteristics in cancers.
Dr. Gandhi said his research presented ODAM as a biomarker for cutaneous melanoma with prognostic implications as ODAM has shown to up-regulate in the primary tumors of patients with sentinel lymph node positive melanoma. ODAM was first detected by Alan Solomon, MD, Director, Human Immunology and Cancer Program and is currently being researched by a team including Dr. Gandhi; Todd Bruker, MD; Sabina Siddiqui, MD; Daniel Kestler, PhD; Keith Gray, MD; John Bell, MD; and James Lewis, MD.
"I presented about a disease process that everyone else probably knew more about than me. I was presenting new data, which was exciting. The experience also helped me with my public speaking and got me more excited about my research. The participants asked questions and brought up points we hadn't thought of before that we are now looking at as we write the paper," Dr. Gandhi said.
Dr. Gandhi said he thanks the Graduate School of Medicine and the Department of Surgery for the opportunity to attend the conference. "It's not often we get to go to an international conference."
Dr. Bruker, Pathology resident, also recently presented ODAM research at an international conference for cutting-edge peptide and protein research in Beijing, China.
